Therapeutic strategies targeting cancer stem cells.
Increasing studies have demonstrated a small proportion of cancer stem cells (CSCs) exist in the cancer cell population. CSCs have powerful self-renewal capacity and tumor-initiating ability and are resistant to chemotherapy and radiation. Conventional anticancer therapies kill the rapidly proliferating bulk cancer cells but spare the relatively quiescent CSCs, which cause cancer recurrence. So it is necessary to develop therapeutic strategies acting specifically on CSCs. In recent years, studies have shown that therapeutic agents such as metformin, salinomycin, DECA-14, rapamycin, oncostatin M (OSM), some natural compounds, oncolytic viruses, microRNAs, cell signaling pathway inhibitors, TNF-related apoptosis inducing ligand (TRAIL), interferon (IFN), telomerase inhibitors, all-trans retinoic acid (ATRA) and monoclonal antibodies can suppress the self-renewal of CSCs in vitro and in vivo. A combination of these agents and conventional chemotherapy drugs can significantly inhibit tumor growth, metastasis and recurrence. These strategies targeting CSCs may bring new hopes to cancer therapy.
Department of Gastroenterology, Changhai Hospital of Second Military Medical University, Shanghai, China.
Xiaoyan
X
Ning
Jianchang
J
Shu
Yiqi
Y
Du
Qiwen
Q
Ben
Zhaoshen
Z
Li
D000818:Animals; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000628:therapy*; D014411:Neoplastic Stem Cells / Q000187:drug effects* / Q000473:pathology / Q000502:physiology* / Q000821:virology; D015398:Signal Transduction
cancer stem cell; target; therapy